MedTrace Logo

Arcos Revision Stem: Evaluation of Clinical Performance

NCT01820611 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 74

Last updated 2025-01-20

Study results available
· View outcomes & findings →

Summary

The primary purpose of this study is to evaluate the clinical performance of the Arcos Revision Stem system, determine the stability of the implants, and evaluate any relationship between Paprosky bone defect level and the success of the Arcos Stem.

Conditions

Interventions

DEVICE

Arcos Revision Stem System

Revision Hip System

Sponsors & Collaborators

  • Zimmer Biomet

    lead INDUSTRY

Principal Investigators

  • Hassan Achakri · Zimmer Biomet

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2021-06-14
Completion
2021-06-14

Countries

  • Finland
  • Spain
  • Sweden
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01820611 on ClinicalTrials.gov